Verkhratsky’s scientific journey is as remarkable as his discoveries. Beginning his career in the late 1970s at Soviet-era Kiev, he was immersed in the nascent field of electrophysiology, collaborating with some of the luminaries who later received Nobel acclaim for their patch-clamp techniques. These early experiences laid a solid electrophysiological foundation, but his intellectual trajectory took a transformative turn in 1989 when Helmut Kettenmann introduced him to neuroglial research during his time in Heidelberg. This encounter catalyzed a redefinition of his scientific focus toward the complex roles of glial cells.

Central to Verkhratsky’s breakthroughs is the revelation of intracellular excitability in neuroglia, a stark contrast to the well-characterized electrical excitability of neurons. Unlike neurons, which rely on plasma membrane-driven action potentials, glial cells exhibit intracellular signaling governed by intricate spatiotemporal dynamics of ions and second messengers such as calcium and sodium. His landmark 1990 publication detailed the presence of voltage-gated calcium channels in oligodendrocyte precursors—cells capable of generating action potential-like phenomena despite their non-neuronal identity. Further advancing this concept, Verkhratsky proposed astrocytic sodium signaling as a rapid, homeostatic response mechanism, translating neuronal activity into astrocytic modulation, thus highlighting glia’s role in maintaining brain equilibrium.

This conceptual revolution carries profound therapeutic implications. Targeting neuroglial ion channels and second messenger pathways offers a novel strategy to restore cerebral homeostasis altered in various neuropathologies. Such an approach differs fundamentally from neuron-focused interventions by potentially preventing or mitigating secondary damage cascades that follow brain injuries and neurodegenerative processes. The prospect of modulating glial function introduces new hope for conditions long considered intractable, including stroke, chronic pain syndromes, and dementia.

One of the most disruptive findings from Verkhratsky’s research confronts the dominant toxic gliosis hypothesis. Traditionally, glial cells were viewed primarily as latent instigators of neuronal damage via inflammatory overactivation. Contrarily, Verkhratsky’s data indicate that in aging and disease, neuroglia undergo atrophy and functional decline rather than hyperactivation. He posits that it is this loss of glial homeostatic support—not hostile inflammation—that precipitates and propagates neuronal injury. This fresh perspective reframes glial cells as crucial neuroprotective agents whose deterioration may be a root cause of pathology rather than a secondary consequence.

The implications of neuroglial atrophy extend across diverse neurological disorders. In Alzheimer’s disease, astroglial atrophy correlates strongly with neuronal degeneration. Multiple sclerosis exhibits parallel patterns with dysfunctional glia accompanying demyelination. Even cerebral small vessel disease, historically interpreted through purely vascular lenses, involves significant glial malfunction. These findings suggest that therapeutic paradigms should shift toward enhancing glial viability and function instead of merely dampening inflammation, thereby potentially slowing or arresting disease progression.

Verkhratsky’s interest in broadening the therapeutic landscape includes exploring traditional Chinese medicine (TCM) compounds for their ability to support neuroglial homeostasis. This integrative approach embodies a cross-cultural scientific philosophy that values diverse medical traditions and innovation. Identifying bioactive agents within TCM that potentiate glial functions could accelerate the development of widely accessible, safe, and effective brain therapeutics that complement cutting-edge biomedical research.

An internationalist by philosophy, Verkhratsky’s collaborative network spans the globe. His sustained partnerships with researchers at Kyushu University in Japan have enriched his electrophysiological and molecular insights. Collaborations with Canadian scientists introduced him to the multifaceted roles of microglia, the brain’s resident immune cells, while Chinese colleagues have illuminated complex interactions between oligodendrocytes, microglia, and astrocytes within pathological frameworks. Such global cooperation facilitates holistic understanding, merging distinct scientific traditions and methodologies to unravel the multifarious nature of neuroglia.

Moreover, Verkhratsky’s research breadth is notable for its refusal to be confined to narrow domains. His laboratory concurrently investigates neuropsychiatric disorders, brain trauma, autoimmune diseases, stroke, and chronic pain. This intellectual omnivory reveals surprising mechanistic overlaps; for instance, pathophysiological patterns identified in stroke models have informed psychiatric disorder research, while chronic pain studies shed light on pathologies underlying dementia. This synthesis of knowledge embodies the complexity and interconnectedness of brain diseases.

A towering achievement in Verkhratsky’s career is the publication of a comprehensive 730-page reference book on neuroglia in 2023, co-authored with Arthur Butt. This exhaustive tome chronicles the evolution of neuroglial research from early historical observations to cutting-edge experimental findings and clinical implications. It serves as an indispensable resource for emerging and established neuroscientists, encapsulating the state-of-the-art knowledge required to propel the field forward. The book exists in multiple languages, including a first-of-its-kind Chinese edition, reflecting the international scope of neuroglial investigation.

Recognition from prestigious scientific academies attests to Verkhratsky’s monumental influence. His election to the German National Academy of Sciences Leopoldina, Academia Europaea, and numerous other European academies underscores the transformative nature of his contributions. With over 600 scientific publications, his prolific output continuously reshapes fundamental neuroscience concepts, placing neuroglia at the heart of brain function and dysfunction paradigms.

Despite his theoretical and academic achievements, Verkhratsky maintains a clear-eyed focus on translational impact. He asserts that “knowing pathophysiology makes finding the cure a technical issue,” emphasizing a pragmatic approach that harnesses mechanistic understanding to drive therapeutic innovation. His diversified research portfolio reflects this ethos, assembling puzzle pieces from multiple disease models to inform comprehensive, glia-targeted treatment strategies aimed at restoring brain health globally.

This enlightening interview is part of Genomic Press’s “Innovators & Ideas” series, which spotlights pioneering scientists who redefine their disciplines. By blending profound scientific insights with personal reflections, the series invites readers into the intellectual and human journeys behind groundbreaking discoveries. Professor Verkhratsky’s story serves as a vivid testament to how perseverance, curiosity, and cross-disciplinary collaboration can revolutionize entire fields and offer hope for devastating neurological illnesses.

Brain Medicine (ISSN: 2997-2639 online; 2997-2647 print), the journal publishing this interview, represents a bold frontier for neuroscience research. As a peer-reviewed platform dedicated to bridging fundamental discoveries and clinical applications, it emphasizes translational innovation across all brain disorders and clinical disciplines. The journal’s open access ethos ensures that pioneering research such as Verkhratsky’s is freely available to catalyze progress in neuroscience worldwide.

Subject of Research: People

Article Title: Alexei Verkhratsky: From neuroglial pathophysiology to therapeutic strategies for brain disorders

News Publication Date: 26-Aug-2025

Web References:
https://doi.org/10.61373/bm025k.0101

References:
A. Verkhratsky, B. Li, S. Duan, Y. Tang & A. Butt, eds, 2023: 神经胶质细胞 [The Textbook of Glial Cells, in Chinese], The People’s Medical Publishing House, ISBN: 978-7-117-34321-3

Image Credits: Alexei Verkhratsky

Keywords: neuroglia, neuroscience, brain function, intracellular excitability, astrocytes, oligodendrocytes, glial atrophy, neurodegeneration, electrophysiology, neurological therapeutics, neuroinflammation, brain homeostasis

At the core of this research lies the vagus nerve, historically celebrated for its role as a bidirectional conduit between the brain and internal organs. While its parasympathetic functions affecting heart rate and digestion are well documented, emerging evidence highlights its integral participation in sensing a broad spectrum of physiological signals, including those derived from immune responses. Cytokines, small but potent proteins secreted by immune cells, orchestrate the inflammatory processes that defend the organism during infection or injury. Yet, the neural substrate that transduces these molecular cues into sensory information has, until now, remained elusive.

The team led by Huerta, Chen, Chaudhry, and colleagues undertook a multidisciplinary approach combining electrophysiology, molecular biology, and cutting-edge imaging to unravel how vagal sensory neurons detect and interpret cytokine signals. Employing sophisticated in vivo calcium imaging techniques in murine models, they observed the activation patterns of vagal sensory neurons upon exposure to specific pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α). Remarkably, distinct populations of sensory neurons exhibited selective responsiveness, indicating a finely tuned neural encoding system that can differentiate between various cytokine profiles.

Delving deeper, the scientists identified specialized receptor subtypes expressed on the membrane of vagal sensory neurons that are sensitive to specific cytokines. These receptors initiate intracellular signaling cascades, resulting in modified neuronal excitability and neurotransmitter release. Notably, the study reveals that cytokine-sensing vagal neurons utilize both ionotropic and metabotropic receptor pathways to transduce biochemical signals into electrical impulses. This dual modality underscores the complexity of neuroimmune dialogue and suggests mechanisms by which transient versus sustained immune challenges may be differentially represented in neural circuits.

One compelling implication of these findings relates to the vagus nerve’s role in the "inflammatory reflex," a neurophysiological pathway that modulates immune responses to maintain homeostasis and prevent excessive inflammation. By deciphering the neural coding of cytokines, the research offers a molecular and functional blueprint for how this reflex may be initiated and modulated. This insight opens avenues for bioelectronic medicine, where precise stimulation of vagal sensory neurons could be tailored to artificially regulate immune activity, representing a paradigm shift away from broadly immunosuppressive pharmacotherapies toward neuromodulation-based treatments.

Furthermore, the research bridges a critical gap between peripheral immune signaling and central nervous system processing. Given the vagus nerve’s extensive projections to brainstem nuclei involved in autonomic control and emotional regulation, the neural representation of cytokines also invites exploration into how inflammatory states might influence mood, cognition, and behavior—phenomena observed clinically but poorly understood mechanistically. Understanding cytokine encoding thus holds promise not only for immunology but also for neuropsychiatric disorders wherein neuroinflammation plays a contributory role.

Methodologically, the work leverages innovative optogenetic tools to control vagal neuron activity with high temporal precision, allowing the dissection of causal relationships between cytokine presence and neuronal response. Complementing this, transcriptomic analyses provided a comprehensive map of receptor expression patterns specific to cytokine-responsive sensory neurons, unveiling molecular markers that could serve as diagnostic or therapeutic targets. The integration of these diverse techniques exemplifies the convergence of neurobiology and immunology into a new interdisciplinary frontier.

In the context of diseases characterized by aberrant cytokine production such as rheumatoid arthritis, sepsis, and inflammatory bowel disease, this research offers a fresh perspective for the development of devices or drugs that modulate vagal sensory pathways to restore balance. By directly targeting the neurons that “sense” pathological cytokine surges, it may be possible to intervene earlier and more effectively than current strategies allow, potentially reducing side effects and improving patient outcomes.

The study also prompts a reevaluation of the vagus nerve’s sensory repertoire beyond traditional modalities like stretch and pressure, confirming its role as a sophisticated sentinel of internal biochemical environments. This sensory complexity likely evolved to enable rapid and dynamic adjustments to physiological perturbations, preserving homeostasis through integrated neural-immune communication. Future research inspired by these findings will undoubtedly investigate how other immune mediators, such as chemokines and danger-associated molecular patterns, are neurally represented.

Moreover, the discovery that vagal sensory neurons encode cytokines with distinct neural signatures raises intriguing questions about the higher-order processing of these signals within the central nervous system. How does the brain interpret this neuroimmune information, and how does it translate into systemic responses? This research lays the foundational framework to answer such questions, offering tools and conceptual paradigms for mapping the neural circuits that mediate the interplay between immunity and neural function.

In summary, Huerta and colleagues have delivered an elegant and compelling demonstration that vagal sensory neurons function as sophisticated detectors of cytokine signals, converting immunological languages into neural codes. This advance deepens our biological understanding and opens transformative potential for bioelectronic medicine and immunomodulatory therapies. As the neuroimmune interface continues to emerge as a critical nexus in health and disease, such insights will catalyze the next generation of diagnostic and therapeutic innovations.

This transformative research not only enriches our knowledge of the molecular dialogues underpinning immunity but also signifies a leap forward in harnessing the nervous system’s intrinsic capacities to monitor and regulate inflammatory processes. The collaborative approach and technical virtuosity displayed in this study offer a roadmap for future explorations at the intersection of neuroscience and immunology, promising breakthroughs that could redefine the management of inflammatory and autoimmune disorders worldwide.

Subject of Research: Neural encoding and sensory representation of cytokines by vagal sensory neurons.

Article Title: Neural representation of cytokines by vagal sensory neurons.

Article References:
Huerta, T.S., Chen, A.C., Chaudhry, S. et al. Neural representation of cytokines by vagal sensory neurons. Nat Commun 16, 3840 (2025). https://doi.org/10.1038/s41467-025-59248-6

Image Credits: AI Generated